yohimbine has been researched along with Anxiety in 102 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 26 (25.49) | 18.7374 |
| 1990's | 31 (30.39) | 18.2507 |
| 2000's | 21 (20.59) | 29.6817 |
| 2010's | 24 (23.53) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mahoney, E; Molho, ES; O'Connor, KA; Pilitsis, JG; Ramirez-Zamora, A; Shin, DS | 1 |
| Gundlach, AL; Kastman, HE; Krstew, EV; Lawrence, AJ; Walker, LC | 1 |
| Baker, NL; Brady, KT; Ferland, C; Hyer, JM; McRae-Clark, AL; Moran-Santa Maria, MM; Sherman, BJ | 1 |
| Arrant, AE; Kuhn, CM; Schramm-Sapyta, NL | 1 |
| Lonstein, JS; Olszewicz, J; Piasecki, CC; Smith, CD; Weera, M | 1 |
| Dickson, CT; Hughes, AM; Lu, L; Treit, D; Yeung, M | 1 |
| Baker, NL; Brady, KT; McRae-Clark, A; Moran-Santa Maria, MM; Ramakrishnan, V | 1 |
| Chen, XQ; Guo, N; He, L; Li, Q; Li, S; Lin, J; Liu, X; Xu, MQ; Zhang, Y | 1 |
| Ayanwuyi, LO; Cheng, K; Ciccocioppo, R; Cippitelli, A; Damadzic, R; Heilig, M; Nasuti, C; Rice, KC; Schank, J; Stopponi, S; Ubaldi, M | 1 |
| Bashiri, H; Rezayof, A; Sahebgharani, M; Tavangar, SM; Zarrindast, MR | 1 |
| Awodele, O; Eluogu, CO; Ishola, IO | 1 |
| Gisquet-Verrier, P; Le Dorze, C | 1 |
| Drummond, PD; Vo, L | 1 |
| Evenden, J; Jonak, G; Ross, L; Zhou, J | 1 |
| Bäuml, J; Castrop, F; Froboese, T; Scherr, M; Schwerthoeffer, D | 1 |
| Bijlsma, EY; de Jongh, R; Groenink, L; Olivier, B | 1 |
| Braun, AA; Skelton, MR; Vorhees, CV; Williams, MT | 1 |
| Bossert, JM; Cifani, C; Nair, SG; Navarre, BM; Pickens, CL; Shaham, Y | 1 |
| Angelici, O; Arban, R; Caberlotto, L; Hédou, GF; Sperk, G; Tasan, RO; Zambello, E; Zanetti, L | 1 |
| George, DT; Geyer, C; Heilig, M; Schwandt, ML; Singley, E; Umhau, JC; Usala, J | 1 |
| Hernádi, I; Tóth, M; Uzsoki, B | 1 |
| Althoff, T; Backhaus, J; Bartmann, U; Braumann, M; Broocks, A; Ehrenthal, D; Hohagen, F; Junghanns, K; Kordon, A; Sommer, M | 1 |
| Bakalli, H; Cai, L; Rinaman, L | 1 |
| Berman, S; Bueller, J; Fitzgerald, L; Gupta, A; Labus, JS; Mandelkern, M; Mayer, EA; Naliboff, BD; Ohning, G; Stains, J; Suyenobu, B; Tillisch, K; Wong, H | 1 |
| Gudasheva, TA; Kolik, LG; Seredenin, SB | 1 |
| Rinaman, L; Zheng, H | 1 |
| Kelley, AE; Schiltz, CA; Schroeder, BE | 1 |
| Salchner, P; Sharp, T; Singewald, N | 1 |
| Goncharenko, NV; Pankrat'ev, DV; Talalaenko, AN | 1 |
| LENNE-BRAUTIGAM, G | 1 |
| GERSHON, S; LANG, WJ | 1 |
| TOPP, G | 1 |
| Carvalho-Netto, EF; Nunes-de-Souza, RL | 1 |
| Packard, MG; Wingard, JC | 1 |
| Alim, T; Belfer, I; Bonne, O; Charney, DS; Geraci, M; Goldman, D; Goldstein, DS; Holmes, C; Luckenbaugh, DA; Manji, H; Neumeister, A; Sharabi, Y | 1 |
| Epstein, DH; Ghitza, UE; Gray, SM; Rice, KC; Shaham, Y | 1 |
| Hogg, S; Jessa, M; Michan, L | 1 |
| Fernández-Guasti, A; Jiménez-Velázquez, G; López-Muñoz, FJ | 1 |
| Ehlert, U; Erni, K; Hebisch, G; Nater, U | 1 |
| Dierssen, M; Estivill, X; Gallego, X; Gratacòs, M; Maldonado, R; Murtra, P; Sahún, I; Trullás, R | 1 |
| Bilbao, A; Braconi, S; Cannella, N; Ciccocioppo, R; Cippitelli, A; Defonseca, FR; Duranti, A; Piomelli, D; Tontini, A | 1 |
| Charney, DS; Heninger, GR; Sternberg, DE | 1 |
| Doaré, L; Simon, P; Soubrié, P; Thiébot, MH | 1 |
| Charney, DS; Heninger, GR; Redmond, DE | 1 |
| Burroughs, GJ; Cole, JC; Laverty, CR; Rodgers, RJ; Sheriff, NC; Sparham, EA | 1 |
| Charney, DS; Germine, M; Goddard, AW; Goodman, WK; Heninger, GR; Krystal, JH; Price, LH; Woods, SW | 1 |
| Matsuda, H; Matsumoto, K; Osanai, M; Shimada, T; Terasawa, K; Watanabe, H | 1 |
| Henningfield, JE; Jaffe, JH; Klein, S; Meisch, RA; Roache, JD; Sampson, A | 1 |
| Charney, DS; Davis, M; Grillon, C; Krystal, JH; Morgan, CA; Southwick, SM | 1 |
| Dunn, RW; La Marca, S | 1 |
| Charney, DS; Cooney, N; Kranzler, HR; Krystal, JH; Webb, E | 1 |
| Griez, E; Pols, H; van der Werf, D; Verburg, K | 1 |
| Chapouthier, G; Jacquot, F; Sara, S; Save, E; Venault, P | 1 |
| Costentin, J; Panissaud, C; Simon, P | 1 |
| Darmani, NA | 1 |
| Charney, DS; Goddard, AW; Goodman, WK; Heninger, GR; Sholomskas, DE; Woods, SW | 1 |
| Cole, BJ; Hillmann, M; Jones, GH; Klewer, M; Seidelmann, D | 1 |
| Bhattacharya, SK | 1 |
| Mizuki, Y; Suetsugi, M; Ushijima, I; Yamada, M | 1 |
| Grasing, KW; Kulkarni, GD; Maines, M; Rosen, RC; Seibold, JR; Sturgill, MG; Thomas, TJ; Trout, JR | 1 |
| Bhattacharya, SK; Chakrabarti, A; Satyan, KS | 1 |
| Bharucha, AE; Camilleri, M; Hanson, RB; Zinsmeister, AR | 1 |
| Broderick, PA | 1 |
| Eroğlu, L; Güven, O | 1 |
| Heal, DJ; Mason, K; Stanford, SC | 1 |
| Lapin, IP | 1 |
| Charney, DS; High, JR; Morgan, CA; Southwick, SM | 1 |
| Sharp, T; Singewald, N | 1 |
| Babaie, A; Etminani, A; Gharib, B; Homayoun, H; Zarrindast, MR | 1 |
| Gordienko, DV; Krivobok, GK; Pankrat'ev, DV; Talalaenko, AN; Zinkovich, II | 1 |
| Tam, SW; Worcel, M; Wyllie, M | 1 |
| Charney, DS; Kosten, TR; Krystal, JH; Petrakis, IL; Southwick, SM; Stine, SM | 1 |
| Ferris, CF; King, JA; Messenger, T | 1 |
| Duxon, MS; Jones, N; King, SM | 1 |
| Balon, R; Berchou, R; Berger, R; Pohl, R; Ramesh, C; Srinivasan, K; Weinberg, P; Yeragani, VK | 1 |
| Coupland, N; Glue, P; Nutt, DJ | 1 |
| Bhattacharya, SK; Mitra, SK | 1 |
| Carey, GJ; Costall, B; Domeney, AM; Jones, DN; Naylor, RJ | 1 |
| Fukuda, N; Wada, T | 1 |
| Costa, R; Marino, A | 1 |
| Handley, SL; Njung'e, K | 1 |
| Guez, D; Malbezin, M; Piette, F; Poitrenaud, J; Sebban, C | 1 |
| File, SE; Johnston, AL | 3 |
| Corbett, R; Dunn, RW; Fielding, S | 1 |
| Ferrari, F; Mangiafico, V; Monti, A; Tartoni, PG | 1 |
| Baldwin, HA; File, SE; Johnston, AL | 1 |
| File, SE; Pellow, S | 1 |
| File, SE; Johnston, AL; Pellow, S | 1 |
| Nesse, RM; Rainey, JM | 1 |
| Mattila, M; Mattila, MJ; Seppala, T | 1 |
| Dieterle, D; Laakmann, G; Schmauss, M | 1 |
| File, SE; Mabbutt, PS; Walker, JH | 1 |
| Bruce, M; Lader, M | 1 |
| Boucard, M; Bouterin, R; Cahen, R; Faurre, L; Vedel, Y | 1 |
| Creveaux-Bourgeat, J; Revol, LA | 1 |
| Boucard, M; Cahen, R; Faurre, LE; Serrano, JJ; Vedel, Y | 1 |
| Galatas, RF; Gallant, DM; Guerrero-Figueroa, R; Rye, MM | 1 |
| Sethy, VH; Winter, JC | 1 |
| Boissier, JR; Simon, P | 1 |
6 review(s) available for yohimbine and Anxiety
| Article | Year |
|---|---|
[Psychiatric effects and side effects of the alpha-2-antagonist yohimbine: a review of literature and case report].
Topics: Adrenergic alpha-Antagonists; Alcoholism; Anxiety; Cocaine-Related Disorders; Female; Humans; Mental Disorders; Suicide; Yohimbine; Young Adult | 2009 |
Yohimbine: a clinical review.
Topics: Adrenergic alpha-Antagonists; Anxiety; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Erectile Dysfunction; Female; Humans; Hypertension; Male; Nitric Oxide; Risk Factors; Treatment Outcome; Urination Disorders; Yohimbine | 2001 |
Challenge tests: assessment of the noradrenergic and GABA systems in depression and anxiety disorders.
Topics: Anxiety; Clonidine; Depression; gamma-Aminobutyric Acid; Growth Hormone; Humans; Hydrocortisone; Norepinephrine; Receptors, Neurotransmitter; Yohimbine | 1992 |
[Further experimental and clinical data on yohimbine with special reference to its anxiogenic effect. An experimental contribution].
Topics: Animals; Anxiety; Behavior, Animal; Brain; Humans; Male; Mice; Rats; Rats, Inbred Strains; Stress, Psychological; Yohimbine | 1991 |
Psychobiology of anxiety and anxiety disorders.
Topics: Animals; Anxiety; Anxiety Disorders; Blood Platelets; Caffeine; Carbolines; Carbon Dioxide; Cats; Disease Models, Animal; Epinephrine; Humans; Hyperventilation; Isoproterenol; Lactates; Lactic Acid; Norepinephrine; Panic; Phobic Disorders; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Research Design; Yohimbine | 1985 |
States of anxiety and their induction by drugs.
Topics: Animals; Anxiety; Caffeine; Carbolines; Epinephrine; Humans; Lactates; Models, Psychological; Risk; Yohimbine | 1986 |
17 trial(s) available for yohimbine and Anxiety
| Article | Year |
|---|---|
Impact of endogenous progesterone on reactivity to yohimbine and cocaine cues in cocaine-dependent women.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adult; Anxiety; Cocaine; Cocaine-Related Disorders; Craving; Cues; Double-Blind Method; Drug-Seeking Behavior; Female; Humans; Middle Aged; Placebos; Progesterone; Recurrence; Stress, Psychological; Yohimbine | 2018 |
Yohimbine administration and cue-reactivity in cocaine-dependent individuals.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adult; Anxiety; Cocaine-Related Disorders; Craving; Cross-Over Studies; Cues; Dehydroepiandrosterone; Double-Blind Method; Female; Humans; Hydrocortisone; Male; Middle Aged; Saliva; Sex Characteristics; Yohimbine; Young Adult | 2014 |
Pharmacologically induced alcohol craving in treatment seeking alcoholics correlates with alcoholism severity, but is insensitive to acamprosate.
Topics: Acamprosate; Adrenergic alpha-2 Receptor Antagonists; Adult; Alcohol Deterrents; Alcohol-Induced Disorders, Nervous System; Alcoholism; Anxiety; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Placebos; Serotonin Receptor Agonists; Severity of Illness Index; Taurine; Treatment Failure; Yohimbine | 2011 |
Psychological and neuroendocrine responses to social stress and to the administration of the alpha-2-receptor antagonist, yohimbine, in highly trained endurance athletes in comparison to untrained healthy controls.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adult; Anxiety; Athletes; Behavior; Blood Pressure; Double-Blind Method; Germany; Heart Rate; Humans; Hydrocortisone; Interpersonal Relations; Male; Neurosecretory Systems; Physical Endurance; Physical Fitness; Psychiatric Status Rating Scales; Stress, Physiological; Stress, Psychological; Yohimbine | 2011 |
Salivary alpha-amylase levels after yohimbine challenge in healthy men.
Topics: Adrenergic alpha-Antagonists; Adult; Affect; alpha-Amylases; Anxiety; Blood Pressure; Double-Blind Method; Epinephrine; Humans; Male; Placebos; Saliva; Stress, Psychological; Yohimbine | 2006 |
Effects of tryptophan depletion on responses to yohimbine in healthy human subjects.
Topics: Adrenergic alpha-Antagonists; Adult; Anxiety; Arousal; Brain; Fear; Female; Humans; Hydrocortisone; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Serotonin; Tryptophan; Yohimbine | 1995 |
Reinforcing effects of triazolam in sedative abusers: correlation of drug liking and self-administration measures.
Topics: Adult; Anxiety; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Hypnotics and Sedatives; Male; Reinforcement Schedule; Reinforcement, Psychology; Self Administration; Substance-Related Disorders; Triazolam; Yohimbine | 1995 |
Yohimbine-facilitated acoustic startle reflex in humans.
Topics: Acoustic Stimulation; Adult; Anxiety; Blinking; Double-Blind Method; Electromyography; Habituation, Psychophysiologic; Humans; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Reflex, Startle; Time Factors; Yohimbine | 1993 |
Specificity of ethanollike effects elicited by serotonergic and noradrenergic mechanisms.
Topics: Adult; Affect; Alcohol Drinking; Alcoholism; Anxiety; Blood Pressure; Cocaine; Ethanol; Hospitalization; Humans; Hydrocortisone; Male; Marijuana Abuse; Middle Aged; Piperazines; Placebos; Prolactin; Receptors, Adrenergic; Receptors, Serotonin; Substance-Related Disorders; Yohimbine | 1994 |
Yohimbine premedication and 35% CO2 vulnerability in healthy volunteers.
Topics: Adolescent; Adult; Anxiety; Carbon Dioxide; Female; Humans; Locus Coeruleus; Male; Norepinephrine; Panic; Premedication; Yohimbine | 1994 |
Effects of the serotonin reuptake inhibitor fluvoxamine on yohimbine-induced anxiety in panic disorder.
Topics: Adult; Anxiety; Arousal; Female; Fluvoxamine; Humans; Hydrocortisone; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Panic; Panic Disorder; Single-Blind Method; Yohimbine | 1993 |
Differential effects of noradrenergic drugs on anxiety and arousal in healthy volunteers with high and low anxiety.
Topics: Adrenergic Agents; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adult; Anxiety; Arousal; Clonidine; Cross-Over Studies; Double-Blind Method; Electroencephalography; Humans; Male; Mental Processes; Methoxyhydroxyphenylglycol; Norepinephrine; Psychiatric Status Rating Scales; Yohimbine | 1996 |
Yohimbine elimination in normal volunteers is characterized by both one- and two-compartment behavior.
Topics: Adult; Affect; Anxiety; Area Under Curve; Double-Blind Method; Epinephrine; Half-Life; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Personality Inventory; Yohimbine | 1997 |
Adrenergic modulation of human colonic motor and sensory function.
Topics: Adrenergic Agents; Adult; Anxiety; Blood Pressure; Clonidine; Colon; Depression; Female; Gastrointestinal Motility; Heart Rate; Humans; Male; Muscle Contraction; Muscle Tonus; Muscle, Smooth; Phenylephrine; Postprandial Period; Pressure; Ritodrine; Sensation; Single-Blind Method; Stress, Psychological; Yohimbine | 1997 |
Yohimbine-induced withdrawal and anxiety symptoms in opioid-dependent patients.
Topics: Adrenergic alpha-Antagonists; Adult; Analgesics, Opioid; Anxiety; Blood Pressure; Double-Blind Method; Female; Humans; Hydrocortisone; Male; Methadone; Methoxyhydroxyphenylglycol; Opioid-Related Disorders; Substance Withdrawal Syndrome; Yohimbine | 2002 |
Almitrine-raubasine and cognitive impairment in the elderly: results of a 6-month controlled multicenter study.
Topics: Aged; Aged, 80 and over; Almitrine; Anxiety; Cognition Disorders; Depression; Double-Blind Method; Drug Combinations; Female; Humans; Male; Memory; Psychological Tests; Secologanin Tryptamine Alkaloids; Yohimbine | 1990 |
Anxiogenic effect of yohimbine in healthy subjects: comparison with caffeine and antagonism by clonidine and diazepam.
Topics: Adult; Anxiety; Arousal; Caffeine; Clonidine; Diazepam; Dose-Response Relationship, Drug; Double-Blind Method; Female; Growth Hormone; Humans; Hydrocortisone; Male; Panic; Prolactin; Yohimbine | 1988 |
79 other study(ies) available for yohimbine and Anxiety
| Article | Year |
|---|---|
Effect of diazepam and yohimbine on neuronal activity in sham and hemiparkinsonian rats.
Topics: Amygdala; Animals; Anti-Anxiety Agents; Anxiety; Diazepam; Motor Activity; Neurons; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Yohimbine | 2017 |
Central amygdala relaxin-3/relaxin family peptide receptor 3 signalling modulates alcohol seeking in rats.
Topics: Alcoholism; Animals; Anxiety; Behavior, Addictive; Central Amygdaloid Nucleus; Ethanol; Male; Rats; Receptors, G-Protein-Coupled; Receptors, Peptide; Relaxin; Self Administration; Signal Transduction; Yohimbine | 2017 |
Use of the light/dark test for anxiety in adult and adolescent male rats.
Topics: Adrenergic alpha-2 Receptor Antagonists; Age Factors; Animals; Antidepressive Agents; Anxiety; Carbolines; Exploratory Behavior; Factor Analysis, Statistical; Light; Male; Motor Activity; Neuropsychological Tests; Rats, Sprague-Dawley; Regression Analysis; Risk-Taking; Time Factors; Yohimbine | 2013 |
Noradrenergic alpha-2 receptor modulators in the ventral bed nucleus of the stria terminalis: effects on anxiety behavior in postpartum and virgin female rats.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Animals; Anxiety; Clonidine; Female; Postpartum Period; Rats; Rats, Long-Evans; Septal Nuclei; Yohimbine | 2013 |
FG7142, yohimbine, and βCCE produce anxiogenic-like effects in the elevated plus-maze but do not affect brainstem activated hippocampal theta.
Topics: Adrenergic alpha-2 Receptor Antagonists; Analysis of Variance; Animals; Anxiety; Biophysics; Brain Stem; Carbolines; Disease Models, Animal; Electric Stimulation; GABA Antagonists; Hippocampus; Male; Maze Learning; Rats; Rats, Sprague-Dawley; Theta Rhythm; Yohimbine | 2013 |
Differential behavioral responses of zebrafish larvae to yohimbine treatment.
Topics: Age Factors; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Dose-Response Relationship, Drug; Larva; Motor Activity; Swimming; Treatment Outcome; Yohimbine; Zebrafish | 2015 |
Neurokinin 1 receptor blockade in the medial amygdala attenuates alcohol drinking in rats with innate anxiety but not in Wistar rats.
Topics: Alcohol Drinking; Amygdala; Animals; Anxiety; Injections, Intraventricular; Male; Maze Learning; Neurokinin-1 Receptor Antagonists; Piperidines; Rats; Rats, Wistar; Yohimbine | 2015 |
Modulatory effects of the basolateral amygdala α2-adrenoceptors on nicotine-induced anxiogenic-like behaviours of rats in the elevated plus maze.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Animals; Anxiety; Basolateral Nuclear Complex; Clonidine; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Male; Maze Learning; Motor Activity; Nicotine; Nicotinic Agonists; Rats, Wistar; Receptors, Adrenergic, alpha-2; Yohimbine | 2016 |
Potentials of Mangifera indica in the treatment of depressive-anxiety disorders: possible mechanisms of action.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Anxiety Disorders; Depression; Depressive Disorder; Male; Mangifera; Metergoline; Mice; Phytotherapy; Plant Bark; Plant Extracts; Plant Stems; Receptors, Adrenergic, alpha-2; Receptors, Biogenic Amine; Receptors, Dopamine D2; Receptors, Serotonin, 5-HT2; Sulpiride; Yohimbine | 2016 |
Sensitivity to trauma-associated cues is restricted to vulnerable traumatized rats and reinstated after extinction by yohimbine.
Topics: Adrenergic alpha-2 Receptor Antagonists; Anhedonia; Animals; Anxiety; Arousal; Conditioning, Classical; Cues; Depression; Disease Models, Animal; Extinction, Psychological; Fear; Male; Motor Activity; Rats; Rats, Sprague-Dawley; Resilience, Psychological; Stress Disorders, Post-Traumatic; Yohimbine | 2016 |
Effect of combined opioid receptor and α
Topics: Adolescent; Adrenergic alpha-2 Receptor Antagonists; Adult; Analgesics, Opioid; Anxiety; Blinking; Cross-Over Studies; Double-Blind Method; Electric Stimulation; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Pain; Receptors, Adrenergic, alpha-2; Receptors, Opioid; Reflex, Startle; Yohimbine; Young Adult | 2017 |
A novel operant conflict procedure using incrementing shock intensities to assess the anxiolytic and anxiogenic effects of drugs.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Aripiprazole; Benzodiazepines; Chlordiazepoxide; Conditioning, Operant; Conflict, Psychological; Dextroamphetamine; Diazepam; Electroshock; Flumazenil; Male; Piperazines; Punishment; Pyridazines; Quinolones; Rats; Rats, Sprague-Dawley; Triazoles; Yohimbine | 2009 |
Fear-potentiated startle, but not light-enhanced startle, is enhanced by anxiogenic drugs.
Topics: Animals; Anxiety; Fear; Light; Male; Pentylenetetrazole; Photic Stimulation; Piperazines; Rats; Rats, Wistar; Reflex, Startle; Yohimbine | 2010 |
Comparison of the elevated plus and elevated zero mazes in treated and untreated male Sprague-Dawley rats: effects of anxiolytic and anxiogenic agents.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Caffeine; Diazepam; Female; Male; Maze Learning; Nicotine; Rats; Rats, Sprague-Dawley; Sex Characteristics; Yohimbine | 2011 |
Role of dorsal medial prefrontal cortex dopamine D1-family receptors in relapse to high-fat food seeking induced by the anxiogenic drug yohimbine.
Topics: Animals; Anxiety; Appetite Regulation; Hyperphagia; Male; Prefrontal Cortex; Rats; Rats, Long-Evans; Receptors, Dopamine D1; Secondary Prevention; Stress, Psychological; Yohimbine | 2011 |
Neuropeptide Y-Y2 receptor knockout mice: influence of genetic background on anxiety-related behaviors.
Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Anxiety; Behavior, Animal; Brain; Brain Chemistry; Dopamine; Female; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microdialysis; Norepinephrine; Phenotype; Receptors, Neuropeptide Y; Reverse Transcriptase Polymerase Chain Reaction; Yohimbine | 2011 |
Novelty response of rats determines the effect of prefrontal alpha-2 adrenoceptor modulation on anxiety.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Animals; Anxiety; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Guanfacine; Imidazoles; Individuality; Isoindoles; Male; Maze Learning; Prefrontal Cortex; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Yohimbine | 2011 |
Yohimbine anxiogenesis in the elevated plus maze is disrupted by bilaterally disconnecting the bed nucleus of the stria terminalis from the central nucleus of the amygdala.
Topics: Amygdala; Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Denervation; Disease Models, Animal; Excitatory Amino Acid Agonists; Ibotenic Acid; Male; Maze Learning; Neural Pathways; Phosphopyruvate Hydratase; Rats; Rats, Sprague-Dawley; Septal Nuclei; Video Recording; Yohimbine | 2012 |
Evidence for alterations in central noradrenergic signaling in irritable bowel syndrome.
Topics: Adult; Anxiety; Arousal; Brain; Central Nervous System; Fatigue; Female; Humans; Image Processing, Computer-Assisted; Irritable Bowel Syndrome; Male; Middle Aged; Nerve Net; Norepinephrine; Positron-Emission Tomography; Psychomotor Performance; Receptors, Adrenergic, alpha-2; Surveys and Questionnaires; Sympathetic Nervous System; Sympatholytics; Wounds and Injuries; Yohimbine; Young Adult | 2012 |
Role of the cholecystokinin system in anxiolytic activity of dipeptide GB-115.
Topics: Animals; Animals, Outbred Strains; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Dipeptides; Freezing Reaction, Cataleptic; Male; Maze Learning; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Rats; Receptor, Cholecystokinin B; Species Specificity; Tetragastrin; Yohimbine | 2012 |
Yohimbine anxiogenesis in the elevated plus maze requires hindbrain noradrenergic neurons that target the anterior ventrolateral bed nucleus of the stria terminalis.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic Neurons; Animals; Anxiety; Hypothalamo-Hypophyseal System; Immunohistochemistry; Male; Pituitary-Adrenal System; Rats; Rats, Sprague-Dawley; Rhombencephalon; Yohimbine | 2013 |
Neural activation profile elicited by cues associated with the anxiogenic drug yohimbine differs from that observed for reward-paired cues.
Topics: Adrenergic alpha-Antagonists; Animals; Anxiety; Cacao; Conditioning, Operant; Cues; Environment; Genes, fos; Immunohistochemistry; Male; Morphine; Motor Activity; Narcotics; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Reward; Yohimbine | 2003 |
Induction of c-Fos expression in specific areas of the fear circuitry in rat forebrain by anxiogenic drugs.
Topics: Adrenergic alpha-Antagonists; Amygdala; Animals; Anxiety; Caffeine; Carbolines; Central Nervous System Stimulants; Cerebral Cortex; Fear; GABA Antagonists; Gene Expression; Hippocampus; Hypothalamus; Immunohistochemistry; Male; Nerve Net; Piperazines; Prosencephalon; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Septum of Brain; Yohimbine | 2003 |
Neurochemical characteristics of the ventromedial hypothalamus in mediating the antiaversive effects of anxiolytics in different models of anxiety.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Anti-Anxiety Agents; Anticonvulsants; Anxiety; Apomorphine; Avoidance Learning; Biguanides; Brain Chemistry; Chlordiazepoxide; Clonidine; Disease Models, Animal; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Droperidol; Drug Interactions; GABA Agents; GABA Antagonists; GABA Modulators; gamma-Aminobutyric Acid; Glutamic Acid; Male; Memantine; Mephenytoin; Microinjections; Pentylenetetrazole; Phentolamine; Picrotoxin; Piperazines; Propranolol; Pyrimidines; Rats; Serotonin; Sulpiride; Ventromedial Hypothalamic Nucleus; Yohimbine | 2003 |
[Therapy of the so-called nervous child].
Topics: Anxiety; Parasympathomimetics; Psychology, Child; Reserpine; Yohimbine | 1957 |
Effects of psychoactive drugs on yohimbine induced responses in conscious dogs. A proposed screening procedure for anti-anxiety agents.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Anxiety Disorders; Blood; Blood Pressure; Blood Pressure Determination; Dogs; Yohimbine | 1963 |
[TRIALS OF SEDAPON IN GYNECOLOGY AND OBSTETRICS WITH WARD PATIENTS].
Topics: Adolescent; Anxiety; Anxiety Disorders; Atropa belladonna; Drug Therapy; Female; Genital Diseases, Female; Geriatrics; Gynecology; Humans; Meprobamate; Obstetrics; Pregnancy; Pregnancy Complications; Yohimbine | 1964 |
Use of the elevated T-maze to study anxiety in mice.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Appetite Depressants; Avoidance Learning; Caffeine; Carbolines; Central Nervous System Stimulants; Conditioning, Classical; Dose-Response Relationship, Drug; Escape Reaction; Imipramine; Inhibition, Psychological; Male; Maze Learning; Mice; Motor Activity; Random Allocation; Reaction Time; Serotonin Agents; Yohimbine | 2004 |
Amygdala and "emotional" modulation of the relative use of multiple memory systems.
Topics: Adrenergic alpha-Antagonists; Amygdala; Animals; Anxiety; Caudate Nucleus; Dose-Response Relationship, Drug; Escape Reaction; Hippocampus; Infusions, Parenteral; Isoquinolines; Male; Maze Learning; Memory; Microinjections; Naphthyridines; Neural Pathways; Rats; Rats, Long-Evans; Yohimbine | 2004 |
Sympathoneural and adrenomedullary functional effects of alpha2C-adrenoreceptor gene polymorphism in healthy humans.
Topics: Adolescent; Adrenal Medulla; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adult; Analysis of Variance; Anxiety; Blood Pressure; Cardiovascular System; Catecholamines; Epinephrine; Female; Gene Deletion; Genetic Predisposition to Disease; Genotype; Heart Failure; Heterozygote; Homozygote; Humans; Male; Norepinephrine; Polymorphism, Genetic; Receptors, Adrenergic, alpha-2; Risk; Sympathetic Nervous System; Time Factors; Yohimbine | 2005 |
The anxiogenic drug yohimbine reinstates palatable food seeking in a rat relapse model: a role of CRF1 receptors.
Topics: Adrenergic alpha-Antagonists; Animals; Anxiety; Behavior, Animal; Conditioning, Operant; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Extinction, Psychological; Food Preferences; Interpersonal Relations; Male; Pyrimidines; Pyrroles; Rats; Rats, Long-Evans; Receptors, Corticotropin-Releasing Hormone; Yohimbine | 2006 |
Prediction of anti-panic properties of escitalopram in the dorsal periaqueductal grey model of panic anxiety.
Topics: Adrenergic alpha-Antagonists; Alprazolam; Animals; Anxiety; Citalopram; Dose-Response Relationship, Drug; Electric Stimulation; Fluoxetine; Hypnotics and Sedatives; Male; Motor Activity; Panic Disorder; Paroxetine; Periaqueductal Gray; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Stereotaxic Techniques; Yohimbine | 2006 |
Influence of pharmacologically-induced experimental anxiety on nociception and antinociception in rats.
Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Aspirin; Behavior, Animal; Diazepam; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Male; Pain; Rats; Rats, Wistar; Time Factors; Yohimbine | 2006 |
Differential responses to anxiogenic drugs in a mouse model of panic disorder as revealed by Fos immunocytochemistry in specific areas of the fear circuitry.
Topics: Animals; Anxiety; Brain; Caffeine; Disease Models, Animal; Fear; Male; Mice; Mice, Transgenic; Oncogene Proteins v-fos; Panic Disorder; Random Allocation; Sodium Lactate; Yohimbine | 2007 |
Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat.
Topics: Adrenergic alpha-Antagonists; Alcohol Drinking; Alcoholism; Amidohydrolases; Animals; Anxiety; Arachidonic Acids; Benzamides; Brain Chemistry; Carbamates; Conditioning, Operant; Cues; Electroshock; Endocannabinoids; Enzyme Inhibitors; Extinction, Psychological; Male; Polyunsaturated Alkamides; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Recurrence; Reinforcement Schedule; Self Administration; Stress, Psychological; Yohimbine | 2008 |
Assessment of alpha 2 adrenergic autoreceptor function in humans: effects of oral yohimbine.
Topics: Adult; Analysis of Variance; Antidepressive Agents; Anxiety; Blood Pressure; Clonidine; Depression; Drug Therapy, Combination; Female; Heart Rate; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Yohimbine | 1982 |
Evidence against the involvement of a noradrenergic mechanism in the release by diazepam of novelty-induced hypophagia in rats.
Topics: Animals; Anxiety; Clonidine; Diazepam; Drug Interactions; Eating; Guanfacine; Guanidines; Humans; Male; Mice; Norepinephrine; Phenylacetates; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Yohimbine | 1984 |
Yohimbine induced anxiety and increased noradrenergic function in humans: effects of diazepam and clonidine.
Topics: Adult; Anxiety; Autonomic Nervous System Diseases; Blood Pressure; Clonidine; Diazepam; Drug Interactions; Female; Humans; Kinetics; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Yohimbine | 1983 |
Anxiolytic-like effects of yohimbine in the murine plus-maze: strain independence and evidence against alpha 2-adrenoceptor mediation.
Topics: Animals; Anxiety; Behavior, Animal; Clonidine; Dioxanes; Genotype; Idazoxan; Imidazoles; Mice; Mice, Inbred Strains; Receptors, Adrenergic, alpha-2; Yohimbine | 1995 |
The modified light/dark transition test in mice: evaluation of classic and putative anxiolytic and anxiogenic drugs.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anti-Anxiety Agents; Anxiety; Carbolines; Darkness; Light; Male; Methamphetamine; Mice; Motor Activity; Picrotoxin; Yohimbine | 1995 |
The alpha-2 antagonists idazoxan and rauwolscine but not yohimbine or piperoxan are anxiolytic in the Vogel lick-shock conflict paradigm following intravenous administration.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Clonidine; Conflict, Psychological; Dioxanes; Drinking Behavior; GABA Antagonists; Idazoxan; Infusions, Intravenous; Male; Piperoxan; Rats; Rats, Sprague-Dawley; Yohimbine | 1994 |
Anxiogenic-like effects of yohimbine and idazoxan in two behavioral situations in mice.
Topics: Adrenergic alpha-Antagonists; Animals; Anxiety; Behavior, Animal; Choice Behavior; Clonidine; Conditioning, Classical; Conflict, Psychological; Dioxanes; Flumazenil; Idazoxan; Male; Mice; Yohimbine | 1993 |
Anxiogenic-like effects induced by stimulation of dopamine receptors.
Topics: Animals; Anxiety; Benzazepines; Carbolines; Dextroamphetamine; Diazepam; Dopamine Agents; Dopamine Antagonists; Haloperidol; Male; Mice; Motor Activity; Pentylenetetrazole; Phenethylamines; Piperazines; Receptors, Dopamine; Receptors, Dopamine D1; Yohimbine | 1993 |
Role of the inhibitory adrenergic alpha 2 and serotonergic 5-HT1A components of cocaine's actions on the DOI-induced head-twitch response in 5-HT2-receptor supersensitive mice.
Topics: Alprenolol; Amphetamines; Animals; Anxiety; Behavior, Animal; Cocaine; Drug Resistance; Male; Mice; Mice, Inbred ICR; Receptors, Adrenergic, alpha; Receptors, Serotonin; Serotonin Receptor Agonists; Yohimbine | 1993 |
Effects of benzodiazepine receptor partial inverse agonists in the elevated plus maze test of anxiety in the rat.
Topics: Animals; Anxiety; Appetite Depressants; Behavior, Animal; Carbolines; Convulsants; Dose-Response Relationship, Drug; GABA-A Receptor Agonists; Male; Maze Learning; Rats; Rats, Wistar; Yohimbine | 1995 |
Anxiogenic activity of centrally administered scorpion (Mesobuthus tamulus) venom in rats.
Topics: Animals; Anxiety; Behavior, Animal; Brain Chemistry; Male; Rats; Scorpion Venoms; Yohimbine | 1995 |
Anxiogenic action of caffeine: an experimental study in rats.
Topics: Animals; Anxiety; Caffeine; Central Nervous System Stimulants; Drug Tolerance; Exploratory Behavior; Male; Phosphodiesterase Inhibitors; Rats; Rats, Wistar; Social Behavior; Substance Withdrawal Syndrome; Yohimbine | 1997 |
Alprazolam, diazepam, yohimbine, clonidine: in vivo CA1 hippocampal norepinephrine and serotonin release profiles under chloral hydrate anesthesia.
Topics: Adrenergic alpha-Antagonists; Alprazolam; Anesthetics, Intravenous; Animals; Anti-Anxiety Agents; Anxiety; Chloral Hydrate; Clonidine; Diazepam; Hippocampus; Male; Microelectrodes; Rats; Rats, Sprague-Dawley; Serotonin; Time Factors; Yohimbine | 1997 |
The effects of moclobemide on the yohimbine-induced anxiogenic action in the elevated plus-maze.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Benzamides; Dose-Response Relationship, Drug; Locomotion; Male; Maze Learning; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Rats; Rats, Wistar; Swimming; Yohimbine | 1998 |
The anxiogenic agents, yohimbine and FG 7142, disrupt the noradrenergic response to novelty.
Topics: Adrenergic alpha-Agonists; Animals; Anxiety; Brain Chemistry; Carbolines; Environment; GABA Antagonists; Male; Microdialysis; Norepinephrine; Rats; Rats, Sprague-Dawley; Yohimbine | 1998 |
Antagonism of kynurenic acid to anxiogens in mice.
Topics: Animals; Anxiety; Brain; Caffeine; Diazepam; Excitatory Amino Acid Antagonists; Injections, Intraperitoneal; Kynurenic Acid; Male; Mice; Motor Activity; Pentylenetetrazole; Phenethylamines; Yohimbine | 1998 |
Yohimbine use in a natural setting: effects on posttraumatic stress disorder.
Topics: Adrenergic alpha-Antagonists; Adult; Anxiety; Humans; Male; Middle Aged; Norepinephrine; Panic Disorder; Recreation; Recurrence; Stress Disorders, Post-Traumatic; Yohimbine | 1999 |
Neuroanatomical targets of anxiogenic drugs in the hindbrain as revealed by Fos immunocytochemistry.
Topics: Adrenergic alpha-Antagonists; Animals; Anxiety; Caffeine; Carbolines; Central Nervous System Stimulants; GABA Antagonists; Genes, fos; Immunohistochemistry; Male; Panic; Rats; Rhombencephalon; Yohimbine | 2000 |
Involvement of adrenergic and cholinergic systems in nicotine-induced anxiogenesis in mice.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Anxiety; Atropine; Clonidine; Hexamethonium; Male; Mecamylamine; Mice; Muscarinic Antagonists; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Phenylephrine; Prazosin; Receptors, Adrenergic, alpha-1; Yohimbine | 2000 |
The role of neurochemical mechanisms of ventromedial hypothalamus in various models of anxiety in rats.
Topics: Adrenergic Agents; Animals; Anxiety; Apomorphine; Avoidance Learning; Disease Models, Animal; Dopamine; Dopamine Agents; GABA Antagonists; gamma-Aminobutyric Acid; Glutamic Acid; Hypothalamus, Middle; Male; Memantine; Microinjections; Neurotransmitter Agents; Phenylephrine; Picrotoxin; Rats; Serotonin; Sulpiride; Yohimbine | 2001 |
Seed finding in golden hamsters: a potential animal model for screening anxiolytic drugs.
Topics: Adrenergic alpha-Agonists; Animals; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anxiety; Appetitive Behavior; Behavior, Animal; Buspirone; Chlordiazepoxide; Clozapine; Cricetinae; Desipramine; Drug Evaluation, Preclinical; Fasting; Fluoxetine; Injections, Intraperitoneal; Male; Mesocricetus; Models, Animal; Stress, Psychological; Yohimbine | 2002 |
Ethopharmacological analysis of the unstable elevated exposed plus maze, a novel model of extreme anxiety: predictive validity and sensitivity to anxiogenic agents.
Topics: Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Anxiety; Behavior, Animal; Caffeine; Carbolines; Central Nervous System Stimulants; Disease Models, Animal; Dose-Response Relationship, Drug; Escape Reaction; Evaluation Studies as Topic; GABA Antagonists; Male; Maze Learning; Pentylenetetrazole; Piperazines; Rats; Reaction Time; Serotonin Receptor Agonists; Yohimbine | 2002 |
Effects of yohimbine on heart rate variability in panic disorder patients and normal controls: a study of power spectral analysis of heart rate.
Topics: Adult; Analysis of Variance; Anxiety; Blood Pressure; Electrocardiography; Female; Heart Rate; Humans; Male; Panic Disorder; Yohimbine | 1992 |
Anxiogenic activity of quinine--an experimental study in rodents.
Topics: Analysis of Variance; Animals; Anxiety; Diazepam; Dose-Response Relationship, Drug; Drinking Behavior; Interpersonal Relations; Male; Movement; Quinine; Rats; Rats, Inbred Strains; Yohimbine | 1992 |
Behavioural effects of anxiogenic agents in the common marmoset.
Topics: Amphetamine; Animals; Anxiety; Behavior, Animal; Caffeine; Callithrix; Carbolines; Diazepam; Motor Activity; Pentylenetetrazole; Yohimbine | 1992 |
Effects of DN-2327, a new anxiolytic, diazepam and buspirone on exploratory activity of the rat in an elevated plus-maze.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Buspirone; Conflict, Psychological; Diazepam; Dose-Response Relationship, Drug; Drug Interactions; Electroshock; Exploratory Behavior; Flumazenil; Isoindoles; Male; Naphthyridines; Pentylenetetrazole; Rats; Rats, Inbred Strains; Spiro Compounds; Yohimbine | 1991 |
Evaluation of marble-burying behavior as a model of anxiety.
Topics: Animals; Anxiety; Carbolines; Diazepam; Dose-Response Relationship, Drug; Evaluation Studies as Topic; Female; Habituation, Psychophysiologic; Male; Mice; Mice, Inbred Strains; Models, Psychological; Sex Factors; Yohimbine | 1991 |
Sodium phenobarbitone reverses the anxiogenic effects of compounds acting at three different central sites.
Topics: Animals; Anxiety; Appetite Depressants; Carbolines; Exploratory Behavior; Male; Pentylenetetrazole; Phenobarbital; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, GABA-A; Social Behavior; Yohimbine | 1989 |
Yohimbine's anxiogenic action: evidence for noradrenergic and dopaminergic sites.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adrenergic alpha-Agonists; Animals; Anxiety; Apomorphine; Azepines; Benzazepines; Clonidine; Dopamine Agents; Ergolines; Guanfacine; Guanidines; Learning; Male; Norepinephrine; Phenylacetates; Phenylephrine; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Receptors, Dopamine; Yohimbine | 1989 |
Effects of 5-HT1A receptor agonists and NMDA receptor antagonists in the social interaction test and the elevated plus maze.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Exploratory Behavior; Male; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; Receptors, Serotonin; Seizures; Social Behavior; Yohimbine | 1989 |
Does anxiety underly imidazole-induced behavioural effects in the rat?
Topics: Animals; Anxiety; Arousal; Behavior, Animal; Blood Pressure; Clonidine; Diazepam; Emotions; Hemodynamics; Imidazoles; Male; Motor Activity; Rats; Rats, Inbred Strains; Social Behavior; Yohimbine | 1989 |
Antagonistic effects of caffeine and yohimbine in animal tests of anxiety.
Topics: Animals; Anxiety; Behavior, Animal; Caffeine; Conflict, Psychological; Drinking; Interpersonal Relations; Male; Motor Activity; Punishment; Rats; Yohimbine | 1989 |
Triazolobenzodiazepines antagonize the effects of anxiogenic drugs mediated at three different central nervous system sites.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Brain; Carbolines; Male; Motor Activity; Pentylenetetrazole; Rats; Receptors, Adrenergic, alpha; Receptors, GABA-A; Social Behavior; Yohimbine | 1985 |
Selective agonists and antagonists for 5-hydroxytryptamine receptor subtypes, and interactions with yohimbine and FG 7142 using the elevated plus-maze test in the rat.
Topics: Animals; Anxiety; Carbolines; Drug Interactions; Male; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Yohimbine | 1987 |
Chronic treatment with imipramine does not reverse the effects of 3 anxiogenic compounds in a test of anxiety in the rat.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Carbolines; Drug Combinations; Imipramine; Male; Pentylenetetrazole; Rats; Time Factors; Yohimbine | 1987 |
The course of panic attacks and agoraphobia.
Topics: Agoraphobia; Anxiety; Chronic Disease; Desipramine; Fear; Follow-Up Studies; Humans; Panic; Phobic Disorders; Yohimbine | 1988 |
Effects of alpha 2-receptor blockade in addition to tricyclic antidepressants in therapy-resistant depression.
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents, Tricyclic; Anxiety; Blood Pressure; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Male; Middle Aged; Norepinephrine; Yohimbine | 1988 |
Comparison of adaptive responses in familiar and novel environments: modulatory factors.
Topics: Adaptation, Psychological; Animals; Anxiety; Carbolines; Environment; Grooming; Pentylenetetrazole; Rats; Rats, Inbred Strains; Sex Characteristics; Time Factors; Yohimbine | 1988 |
[Bivalent neuropharmacologic spectrum of a tricyclic compound derived from benzoxepine].
Topics: Aggression; Animals; Anxiety; Behavior, Animal; Dibenzoxepins; Dogs; Electroshock; Humans; Male; Mice; Nervous System; Rats; Yohimbine | 1970 |
[Modification of normal behavior of Wistar white rats with yohimbine].
Topics: Animals; Anxiety; Avoidance Learning; Behavior, Animal; Conditioning, Classical; Defecation; Escape Reaction; Humans; Male; Rats; Tranquilizing Agents; Yohimbine | 1971 |
[Experimental study of sodium cyclobutane carboxylate and of certain structural analogs on induced behavior].
Topics: Acids; Aggression; Animals; Anxiety; Behavior, Animal; Butyrates; Carboxylic Acids; Chlordiazepoxide; Cyclobutanes; Cycloparaffins; Dogs; Humans; Injections, Intraperitoneal; Injections, Intravenous; Lactones; Methods; Mice; Rats; Sodium; Yohimbine | 1971 |
Effects of yohimbine on CNS structures: neurophysiological and behavioral correlations.
Topics: Amygdala; Animals; Anxiety; Behavior, Animal; Brain; Cats; Central Nervous System; Cerebral Cortex; Dogs; Electroencephalography; Epilepsy; Evoked Potentials; Female; Hippocampus; Humans; Hypothalamus; Injections, Intraperitoneal; Injections, Intravenous; Male; Neurophysiology; Reticular Formation; Thalamus; Yohimbine | 1972 |
Effects of yohimbine and mescaline on punished behavior in the rat.
Topics: Animals; Anxiety; Behavior, Animal; Electroshock; Female; Humans; Mescaline; Punishment; Rats; Reinforcement Schedule; Yohimbine | 1972 |
Evaluation of experimental techniques in the psychopharmacology of emotion.
Topics: Amphetamine; Animals; Anxiety; Autonomic Nervous System; Avoidance Learning; Barbiturates; Behavior, Animal; Brain; Chlordiazepoxide; Conditioning, Classical; Diazepam; Electric Stimulation; Electroshock; Environment; Handling, Psychological; Humans; Light; Methods; Motor Activity; Noise; Psychopharmacology; Social Isolation; Time Factors; Yohimbine | 1969 |